MARK J MANCINI

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology WESTERLY, RI NPI 1477579407

General Payments — all program years on this page

$1,066.78

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $710.31 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $707.2311
Education $3.081

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $87.791
2021 $160.042
2022 $24.231
2023 $84.415
2024 $710.3112

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078173415 Janssen Pharmaceuticals, Inc $26.90 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082025213 CorMedix Inc. $13.44 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086198320 Bayer Healthcare Pharmaceuticals Inc. $25.61 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093997254 Alexion Pharmaceuticals, Inc. $52.21 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118025537 Boehringer Ingelheim Pharmaceuticals, Inc. $19.19 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118025539 Boehringer Ingelheim Pharmaceuticals, Inc. $23.14 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118025541 Boehringer Ingelheim Pharmaceuticals, Inc. $121.60 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139676737 SANOFI-AVENTIS U.S. LLC $150.00 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139676739 SANOFI-AVENTIS U.S. LLC $128.63 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141518477 CALLIDITAS THERAPEUTICS US INC. $124.68 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149922219 Travere Therapeutics, Inc. $3.08 07/22/2024 Education Undisputed 01/23/2026 View at CMS
1149922223 Travere Therapeutics, Inc. $21.83 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.